While a large number of genes and proteins, mainly related to the bone morphogenetic protein (BMP) signaling complex, have historically been the focus of attention for their pathogenic role in human end experimental PAH, the molecular disease concept surrounding vascular endothelial growth factor (VEGF) and its receptors has not yet received adequate consideration. Here, VEGFA is linked to pulmonary arterial hypertension.